The advisory board for Future Forward includes:

Elizabeth Altman - Vice President, Strategy, Motorola Mobile Devices

Randy Bean - Founder and Managing Partner, NewVantage Partners

Charlie Brenner - Senior Vice President, Fidelity Investments

Peter Burrows - Sr. VP, Global IT, adidas Group

James Geshwiler - Managing Director, CommonAngels

Shayne Gilbert - Founder, Silverweave; author, 90 Days to Launch  

Jo Hoppe - VP, CIO, Pegasystems

Scott Kirsner - Innovation Economy columnist, The Boston Globe

Alyssa Stern - Vice President, Future Forward Events, LLC

Reed Sturtevant - Director, Boston Concept Development Center, Microsoft Corporation

Future Forward is one of three high-level programs produced by Future Forward Events, LLC. The other two conferences are:

Nantucket Conference on Entrepreneurship and Innovation
Started in 2000, the Nantucket Conference on Entrepreneurship & Innovation, www.nantucketconference.com, is an annual sold-out gathering of the New England region's most influential high-tech entrepreneurs, executives and investors.  Speakers at the Nantucket Conference have included Lotus founder Mitch Kapor; Motorola CEO Ed Zander; Celera Genomics founder Craig Venter; 3Com Corp founder Bob Metcalfe; Dan Bricklin, co-inventor of the spreadsheet; and Forrester Research CEO George Colony.  Supporters of the program have included Bingham, McCutchen, Ernst & Young, and Silicon Valley Bank. 

Convergence:  The Life Sciences Leaders Forum
Launched in 2004, Convergence, www.convergenceforum.com, brings together high-level life sciences players from around the Northeast to discuss and debate the most pressing topics of interest to the industry - topics like forging strong corporate partnerships; attracting funding from private and public sources; building successful research organizations; streamlining product development and approval; understanding the coming convergence of biology, software, and medical devices; and staying ahead of regulatory changes.  Past speakers have included Robert Langer, ScD, Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering, MIT, Dean Kamen, President, DEKA Research, Alan Crane, CEO, Momenta Pharmaceuticals, and Una Ryan, President & CEO, AVANT Immunotherapeutics, Inc.